New cancer drug LUNA18 tested in early trial – but study halted
Disease control
Terminated
This early-phase study tested a new drug called LUNA18, alone or with other cancer drugs, in 128 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 13, 2026 16:03 UTC